logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Redmond, Michele Emily, Dr
    Born in July 1976
    Individual (1 offspring)
    Officer
    icon of calendar 2015-09-18 ~ now
    OF - Director → CIF 0
  • 2
    Darby, Rosalind May
    Born in July 1967
    Individual (1 offspring)
    Officer
    icon of calendar 2016-06-01 ~ now
    OF - Director → CIF 0
  • 3
    icon of addressOrdinance House, 31 Pier Road, St Helier, Jersey, Jeresy
    Corporate (1 offspring)
    Person with significant control
    icon of calendar 2018-01-23 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% with control over the trustees of a trust → CIF 0
  • 4
    MERCIA FUND MANAGEMENT (NOMINEES) LIMITED
    icon of addressForward House, High Street, Henley-in-arden, England
    Active Corporate (10 parents, 101 offsprings)
    Officer
    icon of calendar 2021-02-01 ~ now
    OF - Director → CIF 0
Ceased 9
  • 1
    Gibson, Stuart James
    Finance Director born in March 1967
    Individual (4 offsprings)
    Officer
    icon of calendar 2015-12-08 ~ 2020-04-10
    OF - Director → CIF 0
  • 2
    Hubbert, Simon
    Director born in July 1967
    Individual (3 offsprings)
    Officer
    icon of calendar 2019-07-01 ~ 2020-02-10
    OF - Director → CIF 0
  • 3
    Alexandroff, James Michael
    Investor born in March 1958
    Individual (15 offsprings)
    Officer
    icon of calendar 2016-04-04 ~ 2016-08-07
    OF - Director → CIF 0
  • 4
    Cooper, Ashley Stephen Charles
    Chief Executive born in October 1960
    Individual (6 offsprings)
    Officer
    icon of calendar 2015-09-18 ~ 2017-11-03
    OF - Director → CIF 0
  • 5
    Sundstrom, Susan Margaret
    Manager born in May 1957
    Individual (2 offsprings)
    Officer
    icon of calendar 2015-04-23 ~ 2016-06-01
    OF - Director → CIF 0
  • 6
    Brooksby, Nigel
    Chairman born in August 1950
    Individual (14 offsprings)
    Officer
    icon of calendar 2017-09-30 ~ 2018-02-08
    OF - Director → CIF 0
  • 7
    Dodd, Isabel
    Investment Associate born in July 1976
    Individual (1 offspring)
    Officer
    icon of calendar 2019-03-21 ~ 2021-02-01
    OF - Director → CIF 0
  • 8
    icon of addressForward House, 17 High Street, Henley-in-arden, West Midlands, England
    Active Corporate (10 parents, 101 offsprings)
    Officer
    2016-04-04 ~ 2019-03-21
    PE - Director → CIF 0
  • 9
    icon of addressRed, Senate House, Tyndall Avenue, Bristol, England
    Active Corporate (9 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-01-23
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

PERTINAX PHARMA LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02024-01-01 ~ 2024-12-31
02023-01-01 ~ 2023-12-31
Par Value of Share
Class 2 ordinary share
02024-01-01 ~ 2024-12-31
Class 3 ordinary share
02024-01-01 ~ 2024-12-31
Class 4 ordinary share
02024-01-01 ~ 2024-12-31
Debtors
251 GBP2024-12-31
112 GBP2023-12-31
Cash at bank and in hand
46,729 GBP2024-12-31
58,424 GBP2023-12-31
Current Assets
46,980 GBP2024-12-31
58,536 GBP2023-12-31
Creditors
Current
1,415 GBP2024-12-31
1,100 GBP2023-12-31
Net Current Assets/Liabilities
45,565 GBP2024-12-31
57,436 GBP2023-12-31
Total Assets Less Current Liabilities
45,565 GBP2024-12-31
57,436 GBP2023-12-31
Equity
Called up share capital
33 GBP2024-12-31
33 GBP2023-12-31
Share premium
2,195,757 GBP2024-12-31
2,195,757 GBP2023-12-31
Retained earnings (accumulated losses)
-2,150,225 GBP2024-12-31
-2,138,354 GBP2023-12-31
Equity
45,565 GBP2024-12-31
57,436 GBP2023-12-31
Other Debtors
Current, Amounts falling due within one year
251 GBP2024-12-31
112 GBP2023-12-31
Trade Creditors/Trade Payables
Current
885 GBP2024-12-31
600 GBP2023-12-31
Other Creditors
Current
530 GBP2024-12-31
500 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
100,000 shares2024-12-31
Class 3 ordinary share
163,556 shares2024-12-31
Class 4 ordinary share
34,127 shares2024-12-31
Profit/Loss
Retained earnings (accumulated losses)
-11,871 GBP2024-01-01 ~ 2024-12-31
Profit/Loss
-11,871 GBP2024-01-01 ~ 2024-12-31
  • PERTINAX PHARMA LIMITED
    Info
    Registered number 09557364
    icon of addressFrp Advisory Trading Limited 4th Floor Abbey House, 32 Booth Street, Manchester M2 4AB
    PRIVATE LIMITED COMPANY incorporated on 2015-04-23 (10 years 7 months). The company status is Liquidation.
    The last date of confirmation statement was made at 2025-04-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.